Caricamento...
Nanotechnology-based drug delivery systems for the treatment of Alzheimer’s disease
Alzheimer’s disease is a neurological disorder that results in cognitive and behavioral impairment. Conventional treatment strategies, such as acetylcholinesterase inhibitor drugs, often fail due to their poor solubility, lower bioavailability, and ineffective ability to cross the blood–brain barrie...
Salvato in:
| Pubblicato in: | Int J Nanomedicine |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Dove Medical Press
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4531021/ https://ncbi.nlm.nih.gov/pubmed/26345528 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S87148 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|